Background: Radium-223 dichloride, or radium-223, is a first-in-class alpha emitter that selectively targets bone metastases with high-energy, short-range alpha particles and is approved for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases, and...

Purpose/Objectives: To provide an in-depth description of the experience of supervised exercise programs among men with prostate cancer and to identify elements critical to optimizing engagement and ongoing exercise participation. Design: Descriptive, qualitative. Setting: A tertiary exercise...

Purpose/Objectives: To investigate how familial communication about prostate cancer (PCa) risk and screening affects sons of men with PCa. Research Approach: Qualitative grounded theory. Setting: Southern California. Participants: 17 Latino sons of PCa survivors. Methodologic Approach: The team...

Studies have documented the efficacy of cancer treatments available, specifically for patients with prostate or breast cancer, but few articles have compared prostate or breast cancer recommendations from the patient's perspective. In this article, the authors compare and contrast published...